SMTL ID : 8e8s.3 (3 other biounits)

9H2 Fab-poliovirus 2 complex

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-6-6-6-6-6-6-mer

Ligands

6 x PLM: PALMITIC ACID(Non-covalent)

PLM.1: 14 residues within 4Å: Chain A: I.86, Y.88, F.106, F.110, F.112, Y.135, I.170, V.172, V.175, Y.181, S.182, H.183, F.213, L.216 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:I.86, A:Y.88, A:Y.88, A:F.106, A:F.112, A:Y.135, A:Y.135, A:I.170, A:V.172, A:V.175, A:Y.181, A:Y.181, A:F.213, A:F.213, A:F.213, A:L.216 Hydrogen bonds: A:Y.88, A:Y.88, A:S.182 Salt bridges: A:H.183 PLM.2: 14 residues within 4Å: Chain G: I.86, Y.88, F.106, F.110, F.112, Y.135, I.170, V.172, V.175, Y.181, S.182, H.183, F.213, L.216 20 PLIP interactions: 20 interactions with chain G Hydrophobic interactions: G:I.86, G:Y.88, G:Y.88, G:F.106, G:F.112, G:Y.135, G:Y.135, G:I.170, G:V.172, G:V.175, G:Y.181, G:Y.181, G:F.213, G:F.213, G:F.213, G:L.216 Hydrogen bonds: G:Y.88, G:Y.88, G:S.182 Salt bridges: G:H.183 PLM.3: 14 residues within 4Å: Chain M: I.86, Y.88, F.106, F.110, F.112, Y.135, I.170, V.172, V.175, Y.181, S.182, H.183, F.213, L.216 20 PLIP interactions: 20 interactions with chain M Hydrophobic interactions: M:I.86, M:Y.88, M:Y.88, M:F.106, M:F.112, M:Y.135, M:Y.135, M:I.170, M:V.172, M:V.175, M:Y.181, M:Y.181, M:F.213, M:F.213, M:F.213, M:L.216 Hydrogen bonds: M:Y.88, M:Y.88, M:S.182 Salt bridges: M:H.183 PLM.4: 14 residues within 4Å: Chain S: I.86, Y.88, F.106, F.110, F.112, Y.135, I.170, V.172, V.175, Y.181, S.182, H.183, F.213, L.216 20 PLIP interactions: 20 interactions with chain S Hydrophobic interactions: S:I.86, S:Y.88, S:Y.88, S:F.106, S:F.112, S:Y.135, S:Y.135, S:I.170, S:V.172, S:V.175, S:Y.181, S:Y.181, S:F.213, S:F.213, S:F.213, S:L.216 Hydrogen bonds: S:Y.88, S:Y.88, S:S.182 Salt bridges: S:H.183 PLM.5: 14 residues within 4Å: Chain Y: I.86, Y.88, F.106, F.110, F.112, Y.135, I.170, V.172, V.175, Y.181, S.182, H.183, F.213, L.216 20 PLIP interactions: 20 interactions with chain Y Hydrophobic interactions: Y:I.86, Y:Y.88, Y:Y.88, Y:F.106, Y:F.112, Y:Y.135, Y:Y.135, Y:I.170, Y:V.172, Y:V.175, Y:Y.181, Y:Y.181, Y:F.213, Y:F.213, Y:F.213, Y:L.216 Hydrogen bonds: Y:Y.88, Y:Y.88, Y:S.182 Salt bridges: Y:H.183 PLM.6: 14 residues within 4Å: Chain 4: I.86, Y.88, F.106, F.110, F.112, Y.135, I.170, V.172, V.175, Y.181, S.182, H.183, F.213, L.216 20 PLIP interactions: 20 interactions with chain 4 Hydrophobic interactions: 4:I.86, 4:Y.88, 4:Y.88, 4:F.106, 4:F.112, 4:Y.135, 4:Y.135, 4:I.170, 4:V.172, 4:V.175, 4:Y.181, 4:Y.181, 4:F.213, 4:F.213, 4:F.213, 4:L.216 Hydrogen bonds: 4:Y.88, 4:Y.88, 4:S.182 Salt bridges: 4:H.183

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Charnesky, A.J. et al., A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun (2023)

Release Date

2023-06-21

Peptides

Capsid protein VP1: AGMSY4
Capsid protein VP2: BHNTZ5
Capsid protein VP3: CIOU06
Capsid protein VP4: DJPV17
9H2 Fab heavy chain: EKQW28
9H2 Fab light chain: FLRX39

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
1

G
1

M
1

S
1

Y
1

4
1

B
2

H
2

N
2

T
2

Z
2

5
2

C
3

I
3

O
3

U
3

0
3

6
3

D
4

J
4

P
4

V
4

1
4

7
4

E
H

K
H

Q
H

W
H

2
H

8
H

F
L

L
L

R
L

X
L

3
L

9
L

Capsid protein VP1

Capsid protein VP2

Capsid protein VP3

Capsid protein VP4

9H2 Fab heavy chain

9H2 Fab light chain

Related Entries With Identical Sequence